Reference no: EM133136737 , Length: word count:1500

Assessment Poster

Description
This assessment task requires you to examine a health issue from the below list (Australian Health Performance Framework - AHPF). The below link has been provided to assist you in beginning your research into your chosen topic.

End-stage kidney disease (ESKD)

At 31 December 2017, approximately 8.8% (2,160) of people receiving treatment for ESKD in Australia were Indigenous Australians. The treatment rate among Indigenous Australians was 5 times that among non-Indigenous Australians, and was highest in Remote areas.

The number of Indigenous Australians beginning ESKD treatment has increased over time, from 240 in 2007 to 352 in 2017. Over the 3-year period 2015 to 2017, Indigenous Australians aged 45-54 and 55-64 were the most likely to begin ESKD treatment (31% and 26% of all new Indigenous patients, respectively).

1 in 5 Indigenous Australian adults showed signs of chronic kidney disease

The health system may pose barriers to accessing transplantation for Indigenous Australians such as reduced likelihood of referral for transplant evaluation; lack of comprehensive investigation of Indigenous patients; and communication and education limitations. There may also be individual patient factors that pose barriers such as incompatibility, higher rates of co-morbidities which affect the acceptability of a kidney transplant, and lower compliance to medical treatment as a result of communication problems (Stumpers & Thomson 2013). Geographic factors may also act as a barrier to transplantation, with research showing that Indigenous patients are not only less likely to be waitlisted for a transplant, but that this disparity increases with remoteness (Garrard et al. 2019; Khanal et al. 2018).

A significant amount of research has gone towards understanding the antecedents of kidney disease among Indigenous Australians, particularly in remote areas. Reviews of the literature have highlighted that kidney disease is multi-determinant, with risk factors including nutritional and developmental disadvantage, low birthweight, childhood infections, family history of kidney disease, as well as adult onset chronic diseases such as hypertension, and diabetes (Hoy 2014; Stumpers & Thomson 2013). Modifiable risk factors also exist including tobacco smoking, overweight and obesity, and insufficient physical activity (Australian Institute of Health and Welfare 2018).

The burden of ESRD is greater everywhere for Indigenous Australians, but there are striking geographical differences in incidence within this population (Fig. 1). A large gradient exists from urban to remote regions (Cass, Cunningham, Snelling, Wang, & Hoy, 2002b).
Can we explain the link between, on the one hand, disadvantage and geographical isolation and on the other, the initiation of renal disease and its progression to ESRD?

Part A

Describe the impact of the health issue at the level of the community AND the population.

Studies show that Indigenous population of Australia with ESKD experience ahigh motility ratedue to large inequality gap, relative socioeconomic disadvantage and not accessing the primary health care(Jesudason& Murphy, 2021).

Can we explain the link bet, ween disadvantage and geographical isolation on the one hand, and the onset of renal disease and progression to ESRD on the other?

Part B
Outline one key point where changes can be made for both the community AND the population. The identified changes should highlight the role of the nurse.

Reviews of the literature have highlighted that kidney disease is multi-determinant, with risk factors including nutritional and developmental disadvantage, low birthweight, childhood infections, family history of kidney disease, as well as adult onset chronic diseases such as hypertension, and diabetes (Hoy 2014; Stumpers & Thomson 2013). Modifiable risk factors also exist including tobacco smoking, overweight and obesity, and insufficient physical activity (Australian Institute of Health and Welfare 2018).

Part C
Develop an action plan, using evidence-based research, to address your chosen health issue, targeting one key area of change that you outlined in part B. Here, you will utilise Stage 2 of the Health Promotion Planning Cycle (HPPC) to identify illness prevention strategies.

Goals
Set 1-2 SMART goals that address the change you have discussed in part B. How to construct a SMART goal is addressed in the above link, subheading ‘Objectives and sub-objectives'. Please ensure that you include each element of SMART in your goal/s.
Strategies and activities

Use complementary strategies that will help to bring about change. Each strategy should link to the SMART goal/s that you have created.

Resources
What resources would need to be available for your plan to succeed? Consider what resources are already available within the community that could be drawn upon. For the purpose of this assessment, you are not required to include a budget.

Evaluation
Describe at least one way that you will review if your plan has worked. You are not required to outline if you plan has worked or not, rather, we are asking you to provide us with details around HOW you will evaluate if your plan has worked.

1500 words

Attachment:- Poster.rar